After FIELD: should fibrates be used to prevent cardiovascular disease in diabetes?

被引：24

作者：

Colhoun, H ^{[1
]}

机构：

[1] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland

来源：

LANCET | 2005年 / 366卷 / 9500期

关键词：

D O I：

10.1016/S0140-6736(05)67668-4

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1829 / 1831

页数：3

共 13 条

[1]

*ACCORD, 2002, ACCORD PURP PROT ABS

[2]

American Diabetes Association, 2005, DIABETES CARE S1, V28, P54

[3]

[Anonymous], 2002, JAMA

[4] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].

Baigent, C ;

Keech, A ;

Kearney, PM ;

Blackwell, L ;

Buck, G ;

Pollicino, C ;

Kirby, A ;

Sourjina, T ;

Peto, R ;

Collins, R ;

Simes, J .

LANCET, 2005, 366 (9493) :1267-1278

[5] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].

Colhoun, HM ;

Betteridge, DJ ;

Durrington, PN ;

Hitman, GA ;

Neil, HAW ;

Livingstone, SJ ;

Thomason, MJ ;

Mackness, MI ;

Charlton-Menys, V ;

Fuller, JH .

LANCET, 2004, 364 (9435) :685-696

[6]

Collins R, 2003, LANCET, V361, P2005

[7] European guidelines on cardiovascular disease prevention in clinical practice -: Third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts) (vol 171, pg 145, 2003) [J].

De Backer, G ;

Ambrosioni, E ;

Borch-Johnsen, K ;

Brotons, C ;

Cifkova, R ;

Dallongeville, J ;

Ebrahim, S ;

Faergeman, O ;

Graham, I ;

Mancia, G ;

Cats, VM ;

Orth-Gomér, K ;

Perk, J ;

Pyörälä, K ;

Rodicio, JL ;

Sans, S ;

Sansoy, V ;

Sechtem, U ;

Silber, S ;

Thomsen, T ;

Wood, D .

ATHEROSCLEROSIS, 2004, 173 (02) :379-391

[8] EFFICACY OF GEMFIBROZIL IN DYSLIPIDEMIC SUBJECTS WITH SUSPECTED HEART-DISEASE - AN ANCILLARY STUDY IN THE HELSINKI HEART-STUDY FRAME POPULATION [J].

FRICK, MH ;

HEINONEN, OP ;

HUTTUNEN, JK ;

KOSKINEN, P ;

MANTTARI, M ;

MANNINEN, V .

ANNALS OF MEDICINE, 1993, 25 (01) :41-45

[9]

Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001

[10] Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study):: randomised controlled trial [J].

Keech, A ;

Simes, RJ ;

Barter, P ;

Best, J ;

Scott, R ;

Taskinen, MR ;

Forder, P ;

Pillai, A ;

Davis, T ;

Glasziou, P ;

Drury, P ;

Kesäniemi, YA ;

Sullivan, D ;

Hunt, D ;

Colman, P ;

d'Emden, M ;

Whiting, M ;

Ehnholm, C ;

Laakso, M .

LANCET, 2005, 366 (9500) :1849-1861

← 1 2 →